Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer

S Jain, TK Wojdacz, YH Su - Expert Review of Molecular …, 2013 - Taylor & Francis
Aberrant DNA methylation is ubiquitous in human cancer and has been shown to occur
early during carcinogenesis, thus providing attractive potential biomarkers for the early …

[PDF][PDF] Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer

S Jain, K Tomasz, YH Su - Expert Rev. Mol. Diagn, 2013 - researchgate.net
Aberrant DNA methylation is ubiquitous in human cancer and has been shown to occur
early during carcinogenesis, thus providing attractive potential biomarkers for the early …

Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer

S Jain, TK Wojdacz, YH Su - Expert review of molecular …, 2013 - pubmed.ncbi.nlm.nih.gov
Aberrant DNA methylation is ubiquitous in human cancer and has been shown to occur
early during carcinogenesis, thus providing attractive potential biomarkers for the early …

Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer

S Jain, TK Wojdacz, YH Su - Expert Review of Molecular …, 2013 - search.proquest.com
Aberrant DNA methylation is ubiquitous in human cancer and has been shown to occur
early during carcinogenesis, thus providing attractive potential biomarkers for the early …

Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer.

S Jain, TK Wojdacz, YH Su - Expert Review of Molecular …, 2013 - europepmc.org
Aberrant DNA methylation is ubiquitous in human cancer and has been shown to occur
early during carcinogenesis, thus providing attractive potential biomarkers for the early …

Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer

S Jain, TK Wojdacz, YH Su - Expert Review of Molecular Diagnostics, 2013 - go.gale.com
Cancer is a disease of the genome, both genetically and epigenetically [1-3]. Identifying the
modifications of the genome underlying the development of cancer should permit …

Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer

S Jain, TK Wojdacz, YH Su - Expert review of …, 2013 - researchdiscovery.drexel.edu
Aberrant DNA methylation is ubiquitous in human cancer and has been shown to occur
early during carcinogenesis, thus providing attractive potential biomarkers for the early …